Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir for asymptomatic and mild COVID-19
jRCT2071200023Completed
- Sponsor
- Health and Labour Sciences Research Grants
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nelfinavir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Health and Labour Sciences Research Grants. Primary endpoint: Time to negative conversion of SARS-CoV-2. Started Jul 2020; status: completed.
02
Drugs
nelfinavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2071200023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200023.